ACE inhibitor improves survival in moderate HF

Enalapril, compared with placebo, decreases patient mortality in NYHA classes II and III heart failure (p = 0.0036).

ACE: angiotensin-converting enzyme; HF: heart failure; NYHA: New York Heart Association.

Data from: The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325:293.